Syros Pharmaceuticals sold a total of $53.15 million in a non-brokered equity investment round. The transaction which started on October 9th, garnered the support of sixteen investors. Two previous unregistered financing rounds raised an estimated $13.25 million.
The company, headquartered in Watertown MA, is led by Nancy Simonian (CEO). Syros Pharmaceuticals elected to keep its revenues undisclosed.
The executive team includes Jorge Conde.
The board of directors includes Douglas Cole, James E Bradner, Philip Sharp, Richard A Young, Robert Nelsen, Stephane Bancel and Vicki Sato.
The company has raised an estimated total of $66.4 million via private unregistered security offerings.
Company: Syros Pharmaceuticals
Amount offered: $53.15 million
Amount placed: $53.15 million
First sale: 10-09-2014
Data as of: 10-24-2014